1. Home
  2. RCKT vs ZEUS Comparison

RCKT vs ZEUS Comparison

Compare RCKT & ZEUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • ZEUS
  • Stock Information
  • Founded
  • RCKT 1999
  • ZEUS 1954
  • Country
  • RCKT United States
  • ZEUS United States
  • Employees
  • RCKT N/A
  • ZEUS N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • ZEUS Metal Fabrications
  • Sector
  • RCKT Health Care
  • ZEUS Industrials
  • Exchange
  • RCKT Nasdaq
  • ZEUS Nasdaq
  • Market Cap
  • RCKT 328.6M
  • ZEUS 352.6M
  • IPO Year
  • RCKT N/A
  • ZEUS 1994
  • Fundamental
  • Price
  • RCKT $3.28
  • ZEUS $33.71
  • Analyst Decision
  • RCKT Buy
  • ZEUS Buy
  • Analyst Count
  • RCKT 13
  • ZEUS 1
  • Target Price
  • RCKT $12.96
  • ZEUS $38.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • ZEUS 55.6K
  • Earning Date
  • RCKT 08-07-2025
  • ZEUS 10-30-2025
  • Dividend Yield
  • RCKT N/A
  • ZEUS 1.90%
  • EPS Growth
  • RCKT N/A
  • ZEUS N/A
  • EPS
  • RCKT N/A
  • ZEUS 1.23
  • Revenue
  • RCKT N/A
  • ZEUS $1,878,204,000.00
  • Revenue This Year
  • RCKT N/A
  • ZEUS $0.48
  • Revenue Next Year
  • RCKT $108.43
  • ZEUS $2.77
  • P/E Ratio
  • RCKT N/A
  • ZEUS $27.48
  • Revenue Growth
  • RCKT N/A
  • ZEUS N/A
  • 52 Week Low
  • RCKT $2.19
  • ZEUS $26.32
  • 52 Week High
  • RCKT $22.01
  • ZEUS $43.60
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • ZEUS 58.07
  • Support Level
  • RCKT $2.88
  • ZEUS $33.15
  • Resistance Level
  • RCKT $3.74
  • ZEUS $34.07
  • Average True Range (ATR)
  • RCKT 0.27
  • ZEUS 0.81
  • MACD
  • RCKT 0.02
  • ZEUS 0.23
  • Stochastic Oscillator
  • RCKT 35.43
  • ZEUS 86.91

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About ZEUS Olympic Steel Inc.

Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.

Share on Social Networks: